none

CUSTOM DENTISTRY CHECKS IN

01-08-2017
by 
in 

One year after the initial rush of popularity and media interest, Australia's own custom dentistry startup has come a long way. 

Though the media might have been quiet, the team at Oventus has been hard at work securing distribution rights and certifications for the gobal market. 

In their latest report, they reveal that they have partnered for global distribution with the world's largest dental prosthetic provider, Modern Dental Group.

The distribution plan is to be funded by the proceeds of their initial share placement, which raised $7 million AUD. 

"We are very pleased to have Modern Dental as our go to market partner and exclusive distributor in the US. Modern Dental has market leading positions in Europe and Australia, and a very strong presence in the US, servicing a quarter of all dentists, via its laboratory business Microdental," said Neil Anderson, CEO of Oventus.

"The manufacturing agreement with Modern Dental is also important, as it will enable us to scale up manufacturing for a global market, at a lower cost. Over the next few months we will be working closely with Modern Dental to put in place the systems, training and marketing to ready us to begin ramping up sales from the October quarter, with the US as the main area of focus initially." 

The company was initially working with the CSIRO from 2014 onwards to help create and test their product and, grow business.

Oventus, a Melbourne based company, was approached by the CSIRO in 2014 after dentist Chris Hart had an idea for a mouthguard that would help airflow bypass for any obstructions in a sleep apnoea sufferers airway.

Now, according to the report, it has made "significant progresss in the execution of its clinical trial program to advance the validation of its proprietary airway technology" in its appliance line, including:

  • A peer reviewed article on the O2Vent Mono has been accepted for publication by the Journal of Dental Sleep Medicine.
  • A Brisbane clinical trial assessing the value of mandibular advancement with the Oventus airway technology is fully recruited.
  • A Perth clinical trial examining the physiological effect of the Oventus airway is now underway.

As for the 3D-dentistry market as a whole, predictions show that the international market is ballooning, with revenue set to hit $3.7 billion by 2021.

Related news & editorials

  1. 26.03.2019
    26.03.2019
    by      In
    Auckland-based Hideaways Bins, run by daughter and father team Jamie and Allen Bertelsen, has won an award in the household appliances and accessories category of the prestigious international Red Dot product design awards for its innovative kitchen bin.
    Their winning product, called Concelo, is... Read More
  2. 26.03.2019
    26.03.2019
    by      In
    The latest Pop Avdel lockbolt systems for jobs requiring safety-critical fastening security are powered by high-efficiency Enerpac pumping systems engineered to complete maintenance and fabrication tasks with optimum speed and minimum downtime.
    Ruggedly engineered Pop Avdel lockbolt systems are... Read More
  3. 25.03.2019
    25.03.2019
    by      In
    Pressure instrumentation is a key part of most process plant, and today’s pressure sensors can play an increased role in the measurement of other process parameters.
    This series of videos looks at some of the fundamental concepts of pressure measurement and illustrates them with VEGA’s state-of-the... Read More
  4. 22.03.2019
    22.03.2019
    by      In
    Mouser Electronics stocks the DACx1416 series of digital-to-analogue convertors (DACs) from Texas Instruments, a pin-compatible family of 16-channel, buffered, high-voltage-output DACs with 16, 14 or 12bit resolution. They address the specific requirements of all Mach-Zehnder modulator technologies... Read More